(1)
A Framework for Decision Making of Migraine Treatment With Anti- CGRP Monoclonal Antibodies: A Guide for Real-World Practice and Public Policies. Headache Med 2020, 11 (3), 72-76. https://doi.org/10.48208/HeadacheMed.2020.20.